Efficacy of AZD3199 in Chronic Obstructive Pulmonary Disease (COPD) Patients

Summary

The purpose of this study is to investigate the efficacy, safety and tolerability of 4 weeks treatment with AZD3199 in moderate to severe COPD.

Timeline

Start

2009-06

Primary completion

2010-03

Completion

2010-03

Publications

• Kuna P, Ivanov Y, Trofimov VI, Saito T, Beckman O, Bengtsson T, Jorup C, Maltais F. Efficacy and safety of AZD3199 vs formoterol in COPD: a randomized, double-blind study. Respir Res. 2013 Jun 3;14(1):64. doi: 10.1186/1465-9921-14-64.

Drugs

Indications